Did you mean behavioral channel and parkinsons?
Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…